申请人:BASF Aktiengesellschaft
公开号:US05100914A1
公开(公告)日:1992-03-31
Arylalkoxycoumarins of the general formula I ##STR1## where R.sup.1 and R.sup.2 independently of one another are each hydrogen, lower alkyl, phenyl or halogen, or the two radicals together form an alkylene bridge of 3 to 5 carbon atoms, R.sup.3 is lower alkyl or halogen, n is an integer of from 0 to 3, m is an integer of from 0 to 4, R.sup.4 is hydrogen or lower alkyl and Ar is a phenyl ring which is monosubstituted to trisubstituted by halogen, C.sub.1 -C.sub.6 -alkyl or C.sub.1 -C.sub.6 -alkoxy or monosubstituted by nitro, cyano or trifluoromethyl or is a naphthyl ring, with the proviso that m is not 0 when Ar is unsubstituted phenyl, processes for their preparation, and drugs prepared therefrom.
通式I的芳基烷氧基香豆素,其中R.sup.1和R.sup.2分别独立地为氢、低碳烷基、苯基或卤素,或两个基团一起形成3到5个碳原子的烷基桥,R.sup.3为低碳烷基或卤素,n为0到3的整数,m为0到4的整数,R.sup.4为氢或低碳烷基,Ar为苯环,被卤素、C.sub.1 -C.sub.6 -烷基或C.sub.1 -C.sub.6 -烷氧基单取代到三取代,或被硝基、氰基或三氟甲基单取代,或为萘环,但当Ar为未取代的苯基时,m不为0,其制备方法及由此制备的药物。